PreOmics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 28
Employees
  • Latest Deal Type
  • Grant
  • Investors
  • 11

PreOmics General Information

Description

Developer of a protein analysis platform intended to develop and provide various technologies for mass spectrometry-based proteomics so as to make research simpler. The company's platform use liquid chromatography that is coupled to a mass spectrometer to feature measurements of parameters like proteins from cells in biopsies and body fluids like blood plasma or urine, enabling researchers to discover and identify proteins as well as analyze post-translational modifications.

Contact Information

Formerly Known As
Precision Proteomics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Am Klopferspitz 19
  • Planegg/Martinsried
  • 82152 Munich
  • Germany
+49 089 00000000

PreOmics Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PreOmics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 31-Aug-2019 00.000 Completed Generating Revenue
7. Later Stage VC (Series A) 10-Jan-2019 00.000 00.000 000.00 Completed Generating Revenue
6. Seed Round 06-Feb-2017 00000 Completed Generating Revenue
5. Grant 06-Jul-2016 0000 00000 Completed Startup
4. Grant 01-Mar-2016 00.000 00000 Completed Startup
3. Grant 17-Feb-2016 00000 00000 Completed Startup
2. Accelerator/Incubator $100K $100K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view PreOmics’s complete valuation and funding history, request access »

PreOmics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a protein analysis platform intended to develop and provide various technologies for mass spectrometry-base
Biotechnology
Munich, Germany
28 As of 2021
00.000
0000000000 00.000

000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000000
Providence, RI
00 As of 0000
0000
000000000 - 0000

00000000

uptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proi
000000000 00000 (0000000000)
Schlieren, Switzerland
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PreOmics Competitors (9)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nabsys Formerly VC-backed Providence, RI 00 0000 000000000 - 0000
000000000 Venture Capital-Backed Schlieren, Switzerland 00 0000 00000000000 0000
00000000 0000000 Venture Capital-Backed Chadds Ford, PA 00 00000 00000000000 00000
00000000000 Private Debt Financed Rosemont, IL 000 000000000 -
000000000 Formerly PE-Backed Billerica, MA 000 00000 00000000 00000
You’re viewing 5 of 9 competitors. Get the full list »

PreOmics Patents

PreOmics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3892994-A1 Pre-fractionation for mass spectrometric analysis Pending 08-Apr-2020 000000000 0
CA-3034049-A1 Hydrophobicity-based flow prevention in sample preparation Pending 28-Oct-2016 000000000
EP-3532181-A1 Hydrophobicity-based flow prevention in sample preparation Pending 28-Oct-2016 000000000
US-20190270035-A1 Hydrophobicity based flow prevention in sample preparation Abandoned 28-Oct-2016 B01D15/22

PreOmics Executive Team (5)

Name Title Board Seat Contact Info
Garwin Pichler Ph.D Co-Founder & Co-Chief Executive Officer
Nils Kulak Ph.D Co-Founder & Co-Chief Executive Officer
Martin Käsemann Chief Operating Officer
Russell Golson Chief Commercial Officer
Michael Ruoff Ph.D Advisor
To view PreOmics’s complete executive team members history, request access »

PreOmics Board Members (2)

Name Representing Role Since
Fabian Mohr Ph.D High-Tech Gründerfonds Advisor and Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

PreOmics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PreOmics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Think.Health Venture Capital Minority 000 0000 000000 0
Tyrolean Business Angel Angel Group Minority 000 0000 000000 0
High-Tech Gründerfonds Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »